SpyGlass Pharma, Inc. Common Stock (SGP) is a publicly traded the market company. As of May 21, 2026, SGP trades at $21.79 with a market cap of $743.41M and a P/E ratio of 0.00. SGP moved +2.92% today. Year to date, SGP is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $20.15 to $32.44. Analyst consensus is strong buy with an average price target of $45.00. Rallies surfaces SGP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SpyGlass Pharma Raises $172.5M in $16 IPO, Sells 10.8M Shares: SpyGlass Pharma closed its IPO of 10,781,250 common shares, including 1,406,250 additional shares from the full underwriters’ option, at $16 per share. The offering generated $172.5 million in gross proceeds, and the stock began trading on the Nasdaq Global Select Market on February 6, 2026.
| Metric | Value |
|---|---|
| Price | $21.79 |
| Market Cap | $743.41M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.07% |
| 52-Week High | $32.44 |
| 52-Week Low | $20.15 |
| Volume | 6 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
5 analysts cover SGP: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $45.00.